Активность

An extraction method was tested for biomonitoring the biofilm samples containing heavy metals. Ivarmacitinib mw The fractionation of metal complexes was performed via C-18-HPLC-ICP-MS and MALDI-MS, respectively. The extraction power of some reagents was determined for the heavy metal extraction from biofilm samples collected in Erdemli coast in the Mediterranean Sea. The ammonium acetate solution giving the highest extraction results was found as a suitable extraction reagent. The concentration and pH of the ammonium acetate solution were optimized and found as 1 M and 5, respectively. The chromatograms of metal complexes with the C-18-HPLC-ICP-MS system were taken to determine the effect of the pH of the metal complexes. After performing the extraction, metal bounded biomolecules were characterized by MALDI-MS for the fractions in the C18-HPLC system. It was seen that ammonium acetate extraction (1M, pH 5) might be used in biomonitoring studies due to relatively simple procedure, short analysis period, and low cost. The evaluation of the applicability of the method in biomonitoring studies might be supported by further studies with biofilms having similar characteristics.For the first time, ultra-high molecular weight polyethylene (UHMWPE) was produced in gas phase process with a new fluidized bed concept where the solids are dispersed phase and the gas is bulk phase as opposed to conventional fluidized bed reactors (FBRs). With this concept, UHMWPE with average molecular weights about 1-6,9 × 106 g mole-1 were produced with a commercial supported Ziegler-Natta catalyst by using a gas phase mini semibatch reactor system. Additionally, optimum conditions of gas phase polymerization for the best results of productivity, catalyst activity, molecular weight and crystallinity were determined by Taguchi experimental design and catalyst stability at the optimum condition was tested by video microscopy polymerization. The characterization of products was carried out experimentally by TGA, DSC, FTIR, and NMR.In this work, 4-(3-morpholin-4-ylpropoxy)phthalonitrile 2, 3-(3-morpholin-4-ylpropoxy)phthalonitrile 3, Co(II)Pc and Mn(III)Pcs containing (3-morpholin-4-ylpropoxy) groups at peripheral and nonperipheral positions were synthesized. Phthalonitrile derivatives (2 and 3), Co(II)Pc and Mn(III)Pcs (2a, 2b, 3a, 3b) were characterized by using FT-IR, NMR (only for 2 and 3), mass and UV-Vis (except 2 and 3) spectral data techniques. Also, electrochemistry of (3-morpholin-4-ylpropoxy) group substituted Co(II)Pc and Mn(III)Pcs were inspected by using cyclic voltammetry. Electrochemical studies show that (3-morpholin-4-ylpropoxy) group substituted Co(II)Pc and Mn(III)Pcs electropolymerized on the Pt working electrode.A series of 1-(4-(2-allylphenoxy)butyl)piperidin-1-ium halides (4a-d) was synthesized and characterized via spectroscopic methods (FTIR, 1 H NMR). The corrosion inhibition of the synthesized halides on carbon steel in water-salt-hydrocarbon environment, saturated with H2 S, was investigated. For this purpose, a series of techniques such as gravimetric measurement, potentiodynamic polarisation, and scanning electron microscope (SEM) were used and some thermodynamic parameters of corrosion process (Δ Gads. , ΔH0ads. , Δ S0ads. ) were evaluated. The steel surface was checked by SEM, and the steel surface showed good surface coverage. The results showed that the synthesized compounds at the concentrations 125, 150 mg ×L-1 have corrosion inhibition activity of 78%-95% by gravimetric measurements and 81%-92% by potentiodynamic measurements at 100, 150 mg ×L-1. The biological activity was examined against sulphate-reducing bacteria (SRB). It was revealed that at the concentration of compounds 4c and 4d, 100 mg ×L-1, the antibacterial activity was 100%.An inexpensive, simple, highly sensitive, and rapid fluorimetric method was developed for the analysis of pseudoephedrine hydrochloride at trace levels. The method is based on the recovery of fluorescence of Rh6G dye due to the interaction of pseudoephedrine hydrochloride with Rh6G-Au NPs complex, which results in the release of Rh6G from the complex and halting fluorescence resonance energy transfer between Rh6G and Au NPs. The intensity of fluorescence was directly proportional to the concentration of the analyte, which was used for its determination. Experimental factors were optimized by response-surface methodology. Under optimum conditions, the calibration curve was linear over the range of 15-150 ng mL-1 and the limit of detection (LOD) was 10 ng mL-1. Percent relative standard deviation (n= 5) for determination of 50 ng mL-1 pseudoephedrine hydrochloride was 3.74%. The method was successfully used for determining the analyte in human blood serum and in pharmaceutical formulations. The possible mechanistic description of the analytical reaction was proposed on the basis of TEM, FT-IR, and fluorescence spectra analysis.A simple and reliable HPLC method was developed and validated for determination of rofecoxib in bovine serum albumin microsphere. The analyses were performed on a C18 column (150 x 4.6 mm, 5 μm particle size) at room temperature with UV detection at 272 nm. The mobile phase was composed of acetonitrile-0.1% o-phosphoric acid solution in water (11, v/v) mixture, and flow rate was set to 1 mL/min. The method was validated according to the international guidelines with respect to stability, linearity range, limit of quantitation and detection, precision, accuracy, specificity, and robustness. The detection and quantification limit of the method were 1.0 μg/mL and 2.5 μg/mL, respectively. The method was linear in the range of 2.5-25 μg/mL with excellent determination coefficients (R2 >0.99). Intra-day and inter-day precision ( less then 1.76% RSD) and accuracy ( less then 0.55 % Bias) values of the method also fulfilled the required limits. It was concluded that the developed method was accurate, sensitive, precise, and reproducible according to the evaluation of the validation parameters. The applicability of the method was confirmed for in vitro quantification of rofecoxib in bovine serum albumin microspheres.